Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab (Q34577559)
scientific article published on November 23, 2010
Language:
(P31) (Q13442814)
(Q45182324)
(P50) (Q125905474)
(P304) 68-74
(P407) (Q1860)
(P433) 1
(P478) 104
(P577) Tuesday, November 23, 2010
(P921) (Q181600)
(Q3658562)
(P953) https://www.nature.com/articles/6605972.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21102589/?tool=EBI
https://europepmc.org/articles/PMC3039819
http://www.nature.com/articles/6605972.pdf
http://www.nature.com/articles/6605972
(P1433) (Q326309)
(P1476) "Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab" (language: en)
(P2093) A. Gualberto
M. L. Hixon
D. D. Karp
D. Li
S. Green
M. Dolled-Filhart
L. G. Paz-Ares
S. Novello
J. Blakely
C. J. Langer
(P2860) (Q37696484)
(Q33604526)
(Q37378581)
(Q37542952)
(Q24652992)
(Q37388937)
(Q37103052)
(Q29619495)
(Q37300867)
(Q27851440)
(Q36862100)
(Q36789089)
(Q42826102)
(Q31809735)
(Q35382945)
(Q41668668)
(Q51579599)
(Q41010710)
(Q34363246)
(Q40489943)
(Q41481089)
(Q46365836)
(Q51789005)
(Q50905279)
(Q57420701)
(Q45950196)
(Q57272603)
(Q44217816)
(Q73365577)
(Q78632840)
(Q73578072)
(Q77997497)
(Q81043109)
(Q81087412)
(Q83810390)
(Q104498684)
other details
description scientific article published on November 23, 2010

External Links